Disease/Infection News

RSS

UH Case Medical Center, ABL partner to design and validate HIV drug resistance tests

University Hospitals Case Medical Center has signed an agreement with Advanced Biological Laboratories, an information technology and diagnostic company based in Luxembourg, to join efforts on the designing and validation of an HIV drug resistance and tropism assay based on next-generation sequencing (NGS).

14 Jan 2015

Mayo Clinic expert explains difference between severe sepsis and septic shock

Sepsis can be a dangerous complication of almost any type of infection, including influenza, pneumonia and food poisoning; urinary tract infections; bloodstream infections from wounds; and abdominal infections.

14 Jan 2015

QDREC software may help find effective treatment for schistosomiasis

For decades, scientists around the world have worked to develop a treatment for schistosomiasis, a debilitating water-born parasite that affects more than 200 million people worldwide. To aid this research, Rahul Singh, professor of computer science at San Francisco State University, has developed software that solves the key challenge of quantitatively assessing the impact of a drug on the parasite.

14 Jan 2015

Cold atmospheric pressure plasma treatment may reduce risk of transmitting norovirus

Treating surfaces with cold atmospheric pressure plasma (CAPP) may reduce the risk of transmitting norovirus, a contagious virus leading to stomach pain, nausea and diarrhea, according to a new study.

14 Jan 2015

Ebola epidemic in Liberia could be eliminated by June, finds study

The Ebola epidemic in Liberia could likely be eliminated by June if the current high rate of hospitalization and vigilance can be maintained, according to a new model developed by ecologists at the University of Georgia and Pennsylvania State University.

13 Jan 2015

Obstetric care during Ebola epidemic are deeply challenging

Obstetric interventions during an Ebola epidemic are deeply challenging say two new commentaries published today (14 January) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

13 Jan 2015

Scientists discover potential solution to antibiotic resistance

A newly developed technique for screening microbes has led to the discovery of a powerful new antibiotic that can easily kill severe infections in mice, without causing side effects.

8 Jan 2015

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for HIV-related Kaposi's Sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of aldoxorubicin for the treatment of Kaposi's Sarcoma (KS) in HIV-infected patients.

8 Jan 2015

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.

8 Jan 2015

Current flu vaccine still offers protection, says Loyola infectious disease specialist

In baseball, three strikes and you're out. The most common annual vaccine targets three strains of flu virus. This year, two vaccine strains are spot on and successfully matched. One strain is partially mismatched, but still believed to offer partial coverage for that strain. The current flu vaccine is still in the game and, more importantly, keeping people well and on the playing field, says a Loyola University Medical Center infectious disease specialist.

8 Jan 2015

Johns Hopkins-led study offers strategy to eradicate HIV

Luring dormant HIV out of hiding and destroying its last cure-defying holdouts has become the holy grail of HIV eradication, but several recent attempts to do so have failed. Now the findings of a Johns Hopkins-led study reveal why that is and offer a strategy that could form a blueprint for a therapeutic vaccine to eradicate lingering virus from the body.

8 Jan 2015

Debiopharm receives FDA Fast Track designation for anti-infectious agent Debio 1450

Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced that the US Food and Drug Administration granted Fast Track designation to its anti-infectious agent Debio 1450, a highly potent antibiotic specifically active against all Staphylococcus species.

8 Jan 2015

Fast-track diagnostics releases CE-labelled Real-time PCR kit to detect Zaire Ebolavirus

Fast-track diagnostics, a global leader in the design, development and manufacture of infectious disease detection kits, has released a CE labelled Real-time PCR kit for the detection of the Zaire Ebolavirus – the strain responsible for the current outbreak in West Africa.

8 Jan 2015

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in Canada to Cipher Pharmaceuticals Inc.

8 Jan 2015

Using HIV drugs to treat AMD: an interview with Dr Mark Young

NRTIs are compounds which were originally developed in the 1960s as anti-cancer agents. They are similar in structure to the bases which make up DNA, and it was hoped that they would interfere with DNA replication in fast-growing cancer cells, slowing down or stopping tumour growth.

7 Jan 2015

ContraVir granted Type B meeting with FDA to discuss proposal for FV-100 Phase 3 trial

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has been granted a Type B meeting with the U.S. Food and Drug Administration (FDA) to discuss its proposal for the design of a Phase 3 trial of ContraVir's lead antiviral candidate, FV-100.

7 Jan 2015

Everyday actions could help prevent spread of flu among college students

As local college students return to Philadelphia from their long winter breaks over the next several days, it is likely that they'll be bringing who-knows-what germs with them from home, said Stacey A. Gorski, PhD, a biology professor who specializes in immunology at University of the Sciences in Philadelphia.

7 Jan 2015

Real-time RT-PCR TaqMan assay helps differentiate active pulmonary TB from LTBI

One of the roadblocks to the eradication of tuberculosis (TB) is the difficulty in identifying patients with latent TB infections (LTBI). Neither the tuberculin skin test (TST) nor interferon-gamma release assays (IGRAs) are capable of distinguishing active from latent infection or predicting the chance of reactivation.

7 Jan 2015

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Johnson & Johnson today announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies.

6 Jan 2015

LEO Pharma submits NDA for aerosol foam formulation to treat patients with plaque psoriasis

LEO Pharma announces it has submitted a New Drug Application (NDA) for calcipotriene and betamethasone dipropionate aerosol foam, 0.005%/0.064%, to the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis.

6 Jan 2015

Disease/Infection News

UH Case Medical Center, ABL partner to design and validate HIV drug resistance tests

Mayo Clinic expert explains difference between severe sepsis and septic shock

QDREC software may help find effective treatment for schistosomiasis

Cold atmospheric pressure plasma treatment may reduce risk of transmitting norovirus

Ebola epidemic in Liberia could be eliminated by June, finds study

Obstetric care during Ebola epidemic are deeply challenging

Scientists discover potential solution to antibiotic resistance

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for HIV-related Kaposi's Sarcoma

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

Current flu vaccine still offers protection, says Loyola infectious disease specialist

Johns Hopkins-led study offers strategy to eradicate HIV

Debiopharm receives FDA Fast Track designation for anti-infectious agent Debio 1450

Fast-track diagnostics releases CE-labelled Real-time PCR kit to detect Zaire Ebolavirus

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Using HIV drugs to treat AMD: an interview with Dr Mark Young

ContraVir granted Type B meeting with FDA to discuss proposal for FV-100 Phase 3 trial

Everyday actions could help prevent spread of flu among college students

Real-time RT-PCR TaqMan assay helps differentiate active pulmonary TB from LTBI

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

LEO Pharma submits NDA for aerosol foam formulation to treat patients with plaque psoriasis

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News